Wikisage, the free encyclopedia of the second generation, is digital heritage
Zonisamide: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
1,2-benzisoxazole-3-methanesulfonamide, that was initally used as anticonvulsant drug and latter as Parkinson-drug | 1,2-benzisoxazole-3-methanesulfonamide, that was initally used as anticonvulsant drug and latter as Parkinson-drug | ||
It inhibitory action of carbonic anhydrase coulby related with perception of taste, and the novo lipogenesis | |||
<ref> | |||
[http://ac.els-cdn.com/S071686401270295X/1-s2.0-S071686401270295X-main.pdf?_tid=015b25bc-89ef-11e7-8ccc-00000aacb35d&acdnat=1503704707_e514043afaffa54860aa6f4fa522df67 Tratamiento farmacológico de la obesidad Pharmacological obesity treatment]</ref> | |||
[http://www.sciencedirect.com/science/article/pii/S0168010217301785?via%3Dihub Zonisamide inhibits monoaminooxidaseand enhances motor perfomance and social activity] | [http://www.sciencedirect.com/science/article/pii/S0168010217301785?via%3Dihub Zonisamide inhibits monoaminooxidaseand enhances motor perfomance and social activity] | ||
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451432/ Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis] | [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451432/ Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis] | ||
[[wikipedia:zonisamide]] | [[wikipedia:zonisamide]] | ||
Revision as of 23:48, 25 August 2017
zonisamide is a 1,2-benzisoxazole-3-methanesulfonamide, that was initally used as anticonvulsant drug and latter as Parkinson-drug
It inhibitory action of carbonic anhydrase coulby related with perception of taste, and the novo lipogenesis
[1]
Zonisamide inhibits monoaminooxidaseand enhances motor perfomance and social activity